What is glucophage
Searched over 200M research papers
Summary
4 papers analyzed
These studies suggest Glucophage is an extended-release form of metformin used to improve glycemic control in type 2 diabetic patients.
Not a yes or no question
To use the Consensus Meter, try asking a simple yes or no question
Research summarized with Copilot
Beta19 papers analyzed
Understanding Glucophage: Uses, Efficacy, and Safety
What is Glucophage?
Glucophage is a brand name for metformin, a medication commonly used to manage type 2 diabetes. It helps control blood sugar levels by improving the body's response to insulin and decreasing the amount of sugar produced by the liver. Glucophage is available in various formulations, including an extended-release version known as Glucophage XR.
Efficacy and Dose-Response Relationship of Glucophage XR
Clinical Studies on Glucophage XR
Several studies have evaluated the efficacy and safety of Glucophage XR in patients with type 2 diabetes who have inadequate glycemic control despite diet and exercise. In two double-blind, randomized, placebo-controlled studies, Glucophage XR demonstrated significant improvements in glycemic control. These studies assessed different dosages and found that the extended-release formulation effectively reduced blood sugar levels over 24 and 16 weeks.
Bioequivalence and Safety
A phase I clinical trial compared the bioequivalence and safety of Glucophage XR with a generic metformin hydrochloride sustained-release (MH-SR) tablet. The study concluded that both formulations were bioequivalent and safe under fasting conditions. The pharmacokinetic parameters, such as the area under the curve (AUC) and maximum concentration (Cmax), were within the acceptable range for bioequivalence. No severe adverse events were reported, although some participants experienced mild adverse drug reactions, including gastrointestinal issues and metabolic conditions.
Mechanism of Action
Metformin and Glycophagy
Metformin, the active ingredient in Glucophage, influences various metabolic pathways. One of the mechanisms involves glycophagy, a selective autophagy process that degrades glycogen. Glycophagy plays a crucial role in maintaining glucose homeostasis in tissues like the liver, heart, and skeletal muscles. It is regulated by several signaling pathways, including the PI3K-Akt/PKB-mTOR pathway. By modulating these pathways, metformin helps improve insulin sensitivity and reduce blood sugar levels .
Conclusion
Glucophage, particularly its extended-release formulation Glucophage XR, is an effective and safe option for managing type 2 diabetes. Clinical studies have demonstrated its efficacy in improving glycemic control, and bioequivalence studies have confirmed that generic versions are equally effective. The medication works through various mechanisms, including the regulation of glycophagy, to maintain glucose homeostasis and improve insulin sensitivity.
Sources and full results
Most relevant research papers on this topic
